The company is a wholly foreign-owned enterprise invested by Mindray (Cayman) Co., Ltd. in Shenzhen on January 25, 1999. The company is mainly engaged in R&D, manufacturing, marketing and service of medical devices, always guided by customer needs, and is committed to providing high-quality products and services to global medical institutions. The company's main products cover three major fields: life information and support, in vitro diagnosis, and medical imaging. Corporate honors: Ranked 43 in the 2015 Global Medical Equipment Supplier Ranking, 2017 China Health Industry Sunshine Award - Most Socially Responsible Company, etc. It won honors such as the 2023 National Adverse Reaction Monitoring Unit, the 2023 Guangdong Provincial Drug Adverse Reaction Monitoring Outstanding Performance Unit, the 2023 14th China Medical Equipment Industry Research China Medical Equipment “Excellent National Brand Gold Award” and “Product Line No. 1”, and the Chief Device Partner of the 5th Veterinary Hospital Director Conference.